|
Al started with Neurogen in 1989, and has been the cornerstone of our medicinal chemistry and informatics initiatives, where he was instrumental in developing our Accelerated Intelligent Drug Discovery (AIDD) technology. Al has helped Neurogen become a world leader in developing compounds for challenging drug targets. Al is responsible for Neurogen’s drug discovery operations, including our chemistry, biology, and discovery technologies organizations. Prior to joining Neurogen, Al was Manager of Neuroscience Chemistry and a Distinguished Research Fellow at Ciba-Geigy. Previously he had served as a research scientist at Pfizer Inc, where he worked on anti-diabetic agents. Al holds a B.S. degree in chemistry from Stevens Institute of Technology in New Jersey and was awarded his Ph.D. in chemistry from Harvard University in Massachusetts.
| 